gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · WSTHealthcareSurgical Instruments

West Pharmaceutical Services, Inc. (WST)

$408.78+0.44%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$406.99▲ 45.47% in range
Nov 3, 2025Low $230.95 · High $416.67Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

West Pharmaceutical Services closed at $408.78 on Nov 4, up 0.44%, 1.9% below its 52-week closing high. Volume of 1.1M shares was 1.49× its 20-day average (above normal).

Split-adjusted performance: +9.7% over one month, +30.8% over six months, +46.1% over one year.

In the quarter ended Sep 30, 2026, revenue was $874.50M, up 8.7% from a year earlier, with a net margin of 24.5%.

Short interest was 2.0M shares at the Oct 15 settlement, down 4.2% from the prior report (2.9% of float, 4.2 days to cover).

Market cap$28.48B69.7M shares
Revenue · quarter$874.5M+8.7% YoY
Diluted EPS$3.02+57.3% YoY
P/E · TTM44.6×P/S 8.4×
Net margin24.5%Gross 39.7%
Dividend yield0.22%$0.22 last paid
52-week range230.95 – 416.67−1.9% from high
Volume1.1M1.49× 20-day avg
Volatility · 60d20.3%Annualised
Short % of float2.9%4.2 days to cover
Net cash$261.2MCash $464.1M
Next earnings—Not scheduled
Split-adjusted performance
1W +1.3%1M +9.7%3M +17.3%6M +30.8%YTD +48.6%1Y +46.1%3Y +27.8%5Y −3.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum72
Revenue growth49
Net margin95
Value (low P/E)27
Size94

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short2.0M−4.2% vs prior
Days to cover4.2Settled Oct 15
% of float2.9%
Short vol. 10d41.4%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
WSTWest Pharmaceutical Services$408.78+0.44%+30.8%+8.7%24.5%44.6$28.48B
DXCMDexCom$88.48+6.64%+46.6%+11.2%20.5%33.3$33.00BCompare
RMDResMed$240.51+5.91%+14.7%+5.9%29.6%21.2$33.83BCompare
MDLNMedline$40.35+18.36%−4.0%—0.8%—$35.40BCompare
SOLVSolventum$89.35+5.42%+25.9%+2.2%4.2%10.6$15.21BCompare
GKOSGlaukos$246.70+5.86%+82.4%+58.0%1.0%—$14.60BCompare
BDXBecton, Dickinson and$209.19+5.56%+44.5%+5.4%7.6%60.6$56.98BCompare
BAXBaxter International$26.50+3.96%+56.1%+5.0%9.9%—$13.71BCompare
PENPenumbra$322.45+0.76%−0.5%+15.6%10.3%80.9$12.71BCompare

News about West Pharmaceutical Services

All news →
West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook RaisedZacks Investment Research · 6d ago▲ PositiveWest Pharmaceutical Services (WST) Q3 Earnings and Revenues Top EstimatesZacks Investment Research · 6d ago▼ NegativeReasons to Add West Pharmaceutical Stock to Your Portfolio NowZacks Investment Research · Sep 18, 2026▲ PositiveInvestors Await Damage Assessment After West Pharmaceutical CyberattackBenzinga · May 12, 2026▼ NegativeWest Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1Benzinga · Apr 23, 2026▲ Positive

Quick answers

What does West Pharmaceutical Services do?
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs.
What is WST's market cap?
$28.48B, based on the Nov 4 close of $408.78.
What is WST's P/E ratio?
44.6× trailing-twelve-month earnings of $638.90M.
Does West Pharmaceutical Services pay a dividend?
Yes. The latest regular dividend was $0.22 per share (ex-date Jul 29), an annualised yield of 0.22%.
How much of WST is sold short?
2.0M shares, 2.9% of float, as of Oct 15, 2026.
What sector is WST in?
Healthcare, in the Surgical Instruments industry.

About West Pharmaceutical Services

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

HQ: Exton, PA10,800 employeesListed Jan 2, 1973westpharma.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology